Literature DB >> 18272784

Cis-dimerization mediates function of junctional adhesion molecule A.

Eric A Severson1, Liangyong Jiang, Andrei I Ivanov, Kenneth J Mandell, Asma Nusrat, Charles A Parkos.   

Abstract

Junctional adhesion molecule-A (JAM-A) is a transmembrane component of tight junctions that has been proposed to play a role in regulating epithelial cell adhesion and migration, yet mechanistic structure-function studies are lacking. Although biochemical and structural studies indicate that JAM-A forms cis-homodimers, the functional significance of dimerization is unclear. Here, we report the effects of cis-dimerization-defective JAM-A mutants on epithelial cell migration and adhesion. Overexpression of dimerization-defective JAM-A mutants in 293T cells inhibited cell spreading and migration across permeable filters. Similar inhibition was observed with using dimerization-blocking antibodies. Analyses of cells expressing the JAM-A dimerization-defective mutant proteins revealed diminished beta1 integrin protein but not mRNA levels. Further analyses of beta1 protein localization and expression after disruption of JAM-A dimerization suggested that internalization of beta1 integrin precedes degradation. A functional link between JAM-A and beta1 integrin was confirmed by restoration of cell migration to control levels after overexpression of beta1 integrin in JAM-A dimerization-defective cells. Last, we show that the functional effects of JAM dimerization require its carboxy-terminal postsynaptic density 95/disc-large/zonula occludins-1 binding motif. These results suggest that dimerization of JAM-A regulates cell migration and adhesion through indirect mechanisms involving posttranscriptional control of beta1 integrin levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18272784      PMCID: PMC2366836          DOI: 10.1091/mbc.e07-09-0869

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  43 in total

1.  Junctional adhesion molecule (JAM) is phosphorylated by protein kinase C upon platelet activation.

Authors:  H Ozaki; K Ishii; H Arai; H Horiuchi; T Kawamoto; H Suzuki; T Kita
Journal:  Biochem Biophys Res Commun       Date:  2000-10-05       Impact factor: 3.575

2.  Junction adhesion molecule is a receptor for reovirus.

Authors:  E S Barton; J C Forrest; J L Connolly; J D Chappell; Y Liu; F J Schnell; A Nusrat; C A Parkos; T S Dermody
Journal:  Cell       Date:  2001-02-09       Impact factor: 41.582

3.  Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin.

Authors:  G Bazzoni; O M Martinez-Estrada; F Orsenigo; M Cordenonsi; S Citi; E Dejana
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

4.  Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1.

Authors:  K Ebnet; C U Schulz; M K Meyer Zu Brickwedde; G G Pendl; D Vestweber
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

5.  Characterization of huJAM: evidence for involvement in cell-cell contact and tight junction regulation.

Authors:  T W Liang; R A DeMarco; R J Mrsny; A Gurney; A Gray; J Hooley; H L Aaron; A Huang; T Klassen; D B Tumas; S Fong
Journal:  Am J Physiol Cell Physiol       Date:  2000-12       Impact factor: 4.249

6.  Platelet agonist F11 receptor is a member of the immunoglobulin superfamily and identical with junctional adhesion molecule (JAM): regulation of expression in human endothelial cells and macrophages.

Authors:  S K Gupta; K Pillarisetti; E H Ohlstein
Journal:  IUBMB Life       Date:  2000-07       Impact factor: 3.885

7.  Cloning of the human platelet F11 receptor: a cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation.

Authors:  M B Sobocka; T Sobocki; P Banerjee; C Weiss; J I Rushbrook; A J Norin; J Hartwig; M O Salifu; M S Markell; A Babinska; Y H Ehrlich; E Kornecki
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

8.  Human junction adhesion molecule regulates tight junction resealing in epithelia.

Authors:  Y Liu; A Nusrat; F J Schnell; T A Reaves; S Walsh; M Pochet; C A Parkos
Journal:  J Cell Sci       Date:  2000-07       Impact factor: 5.285

9.  Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM).

Authors:  A Del Maschio; A De Luigi; I Martin-Padura; M Brockhaus; T Bartfai; P Fruscella; L Adorini; G Martino; R Furlan; M G De Simoni; E Dejana
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

10.  JAM-A regulates permeability and inflammation in the intestine in vivo.

Authors:  Mike G Laukoetter; Porfirio Nava; Winston Y Lee; Eric A Severson; Christopher T Capaldo; Brian A Babbin; Ifor R Williams; Michael Koval; Eric Peatman; Jacquelyn A Campbell; Terence S Dermody; Asma Nusrat; Charles A Parkos
Journal:  J Exp Med       Date:  2007-11-26       Impact factor: 14.307

View more
  44 in total

Review 1.  Tight junctions in the testis: new perspectives.

Authors:  Dolores D Mruk; C Y Cheng
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-05-27       Impact factor: 6.237

Review 2.  New aspects of the molecular constituents of tissue barriers.

Authors:  H C Bauer; A Traweger; J Zweimueller-Mayer; C Lehner; H Tempfer; I Krizbai; I Wilhelm; H Bauer
Journal:  J Neural Transm (Vienna)       Date:  2010-09-24       Impact factor: 3.575

3.  Inhibition of junctional adhesion molecule-A/LFA interaction attenuates leukocyte trafficking and inflammation in brain ischemia/reperfusion injury.

Authors:  Nikola Sladojevic; Svetlana M Stamatovic; Richard F Keep; Jamison J Grailer; J Vidya Sarma; Peter A Ward; Anuska V Andjelkovic
Journal:  Neurobiol Dis       Date:  2014-03-21       Impact factor: 5.996

Review 4.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

5.  JAM-A regulates epithelial proliferation through Akt/β-catenin signalling.

Authors:  Porfirio Nava; Christopher T Capaldo; Stefan Koch; Keli Kolegraff; Carl Robert Rankin; Attila E Farkas; Mattie E Feasel; Linheng Li; Caroline Addis; Charles A Parkos; Asma Nusrat
Journal:  EMBO Rep       Date:  2011-03-04       Impact factor: 8.807

Review 6.  Neutrophil-Epithelial Interactions: A Double-Edged Sword.

Authors:  Charles A Parkos
Journal:  Am J Pathol       Date:  2016-04-12       Impact factor: 4.307

Review 7.  Junctional proteins of the blood-brain barrier: New insights into function and dysfunction.

Authors:  Svetlana M Stamatovic; Allison M Johnson; Richard F Keep; Anuska V Andjelkovic
Journal:  Tissue Barriers       Date:  2016-02-26

8.  Junctional adhesion molecule A interacts with Afadin and PDZ-GEF2 to activate Rap1A, regulate beta1 integrin levels, and enhance cell migration.

Authors:  Eric A Severson; Winston Y Lee; Christopher T Capaldo; Asma Nusrat; Charles A Parkos
Journal:  Mol Biol Cell       Date:  2009-01-28       Impact factor: 4.138

9.  Mesenchymal stem cells with modification of junctional adhesion molecule a induce hair formation.

Authors:  Minjuan Wu; Xiaocan Guo; Ling Yang; Yue Wang; Ying Tang; Yongji Yang; Houqi Liu
Journal:  Stem Cells Transl Med       Date:  2014-02-20       Impact factor: 6.940

Review 10.  Structural determinants of Junctional Adhesion Molecule A (JAM-A) function and mechanisms of intracellular signaling.

Authors:  Eric A Severson; Charles A Parkos
Journal:  Curr Opin Cell Biol       Date:  2009-07-14       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.